Verition Fund Management’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
AIM
SUT
Verition Fund Management's CELL Position: Q4 2021 in Review
Verition Fund Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2021, closing a stake of 12,218 shares — an estimated $239K sold.
Verition Fund Management first reported a position in CELL in Q2 2021 and held it in 2 quarters. The position peaked at $239K in Q3 2021. 132 funds tracked by Wall St. Rank hold CELL as of Q4 2021.
- Verition Fund Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
- Verition Fund Management sold 12,218 PhenomeX Inc. Common Stock shares in Q4 2021, an estimated $239K.
- Verition Fund Management first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 2 quarters.
- Verition Fund Management's PhenomeX Inc. Common Stock position peaked at $239K in Q3 2021.
- 132 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2021.
Based on Verition Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.